Sale!

CITED2 Gene Atrial Septal Defect Type 8 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CITED2 gene, known for its role in embryonic development, has been linked to Atrial Septal Defect Type 8 (ASD8), a congenital heart anomaly characterized by a hole in the wall (septum) that divides the heart’s upper chambers (atria). This condition can lead to complications such as heart failure, atrial fibrillation, and pulmonary hypertension if left untreated. The genetic test for ASD8, focusing on mutations within the CITED2 gene, is a crucial diagnostic tool for identifying individuals at risk of developing this condition or for confirming a diagnosis in patients presenting symptoms of ASD8.

Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test for the CITED2 gene’s involvement in Atrial Septal Defect Type 8 offers a comprehensive analysis for patients and their families. With a cost of 4400 AED, the test is both a critical step in the management and treatment plan for affected individuals and a preventive measure for at-risk family members. By identifying the genetic underpinnings of ASD8, healthcare providers can tailor interventions more effectively and provide targeted advice on the condition’s prognosis and management.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CITED2 Gene Atrial Septal Defect Type 8 Genetic Test

Welcome to DNA Labs UAE, where we offer the CITED2 Gene Atrial Septal Defect Type 8 Genetic Test. This test is designed to detect variations or mutations in the CITED2 gene, which may be associated with Atrial Septal Defect Type 8 (ASD8), a congenital heart defect.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Cardiovascular Pneumology Disorders
  • Doctor: Cardiologist
  • Test Department: Genetics

Pre Test Information

Prior to undergoing the CITED2 Gene Atrial Septal Defect Type 8 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with the CITED2 gene.

Test Details

The CITED2 gene is responsible for producing a protein called Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2. This protein plays a crucial role in regulating gene expression and is involved in the development of various organs, including the heart.

Atrial Septal Defect Type 8 (ASD8) is a congenital heart defect characterized by an abnormal opening in the wall that separates the two upper chambers of the heart (atria). This defect leads to inefficient circulation and potential complications due to the mixing of oxygen-rich and oxygen-poor blood.

The NGS Genetic Test, also known as Next-Generation Sequencing, is a high-throughput sequencing technology that allows for the analysis of multiple genes simultaneously. This test specifically focuses on the CITED2 gene and can detect variations or mutations in its DNA sequence that may be associated with ASD8.

By performing the CITED2 Gene Atrial Septal Defect Type 8 Genetic Test, healthcare professionals can identify specific genetic variations responsible for the development of ASD8. This information is crucial for diagnosing individuals with ASD8 and may provide insights into potential treatment options or genetic counseling for affected individuals and their families.

Test Name CITED2 Gene Atrial septal defect type 8 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CITED2 Gene Atrial septal defect type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CITED2 Gene Atrial septal defect type 8 NGS Genetic DNA Test gene CITED2
Test Details

The CITED2 gene is a gene that provides instructions for making a protein called Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2. This protein is involved in regulating gene expression and plays a crucial role in the development of various organs, including the heart.

Atrial septal defect type 8 (ASD8) is a congenital heart defect characterized by an abnormal opening in the wall that separates the two upper chambers of the heart (atria). This defect allows oxygen-rich blood to mix with oxygen-poor blood, leading to inefficient circulation and potential complications.

NGS (Next-Generation Sequencing) Genetic Test is a type of genetic testing that uses high-throughput sequencing technologies to analyze multiple genes simultaneously. This test can detect variations or mutations in the DNA sequence of the CITED2 gene, which may be associated with ASD8.

By performing a NGS Genetic Test for the CITED2 gene, healthcare professionals can identify specific genetic variations that may be responsible for the development of ASD8. This information can help in diagnosing individuals with ASD8 and may also provide insights into potential treatment options or genetic counseling for affected individuals and their families.